天美传媒

Dr. Ilyas is a board-certified Orthopaedic Surgeon with a certificate of added qualification in Hand Surgery. He specializes in hand, wrist, elbow, and orthopaedic trauma surgery. Dr. Ilyas has a particular interest in fracture surgery, nerve injury, opioids, and pain management in orthopaedic surgery and is considered an expert in "wide awake hand surgery." Dr. Ilyas also served as the Consulting Hand Surgeon to the Philadelphia 76ers and the Philadelphia Eagles.
Dr. Ilyas is an Alpha Omega Alpha graduate of MCP-Hahnemann College of Medicine of Drexel University. After medical school he completed his Orthopaedic Surgery training at Temple University Hospital. He subsequently completed his fellowship as a Harvard Fellow at the prestigious Massachusetts General Hospital in Boston prior to returning to the Philadelphia area.

Dr. Ilyas has an extensive research portfolio. He has published over 150 scientific studies and papers, authored several textbook chapters, and serves as an editor and reviewer for multiple journals and textbooks. His research has most recently focused on opioids and pain management strategies to decrease postoperative opioid use and dependency. His work culminated in the launch of the new Rothman Orthopaedic Institute's Foundation for Opioid Research and Education. 

In addition to his busy clinical practice and research, Dr. Ilyas is a dedicated educator. He maintains a full academic schedule, which includes serving as a Professor of Orthopaedic Surgery at Sidney Kimmel Medical College and as the Program Director of the Hand & Upper Extremity Surgery Fellowship. Dr. Ilyas also lectures extensively nationally and internationally. 

Beyond his clinical practice and academic responsibilities, Dr. Ilyas is actively involved in several professional societies, including serving as the President of the Pennsylvania Orthopaedic Society. In addition, he is involved in the design and development of various fracture and joint replacement implants for the upper extremity and other technologies used by hand surgeons.

Dr. Ilyas is annually recognized as a “Top Doc” in Philadelphia and Main Line Today magazines. Most recently, he was privileged to be the top-ranked Orthopaedic Hand Surgeon among his peers in Main Line Today.

Thomas Stopka is an Epidemiologist and Professor with the Department of Public Health and Community Medicine at Tufts University School of Medicine. Through his research, Dr. Stopka explores the interconnectedness of substance use, social and behavioral risk factors, and overdose and infectious disease outcomes among high-risk and often hidden populations through community-engaged, interdisciplinary, multi-methods, applied epidemiological research studies. His major research interests focus on the overlap substance use, infectious disease (HCV, HIV, and STIs), and opioid overdose. He employs qualitative, biostatistical, geographic information systems (GIS), spatial epidemiological, and laboratory approaches in his studies to assess the risk landscape, access to health services, and implement and test public health and clinical interventions to address health disparities. Stopka is currently a multi-Principal Investigator (MPI) on three National Institute on Drug Abuse (NIDA)-funded studies that aim to: 1) Predict future opioid overdoses in Massachusetts employing Bayesian spatiotemporal models to inform pre-emptive public health responses; 2) determine the best timing for extended-release medications (XR-Buprenorphine) for opioid use disorder among incarcerated people in Massachusetts; and 3) assess the effectiveness of a mobile telemedicine-based hepatitis C treatment intervention among rural people who inject drugs. He is also a Co-Investigator on the National Institute of Health (NIH)-funded HEALing Communities Study to reduce opioid overdose deaths in Massachusetts, in which he is leading GIS and spatial epidemiological analyses. These and other studies that Stopka is working on employ: 1) ethnographic and qualitative approaches to assess contextual factors tied to salient exposures and outcomes of interest and to generate hypotheses; 2) innovative epidemiological, legal, and policy scans to assess substance use-related morbidity and mortality and health services landscape; 3) spatiotemporal methods to explore the distribution of measures that affect risk, and to determine the geolocation of and access to current services, as well as gaps; and, 4) Bayesian spatiotemporal dynamic modeling approaches to inform small area forecasting of opioid-related mortality.